MedTrace Logo

Body Impedance Analysis to Detect ICUAW

NCT05572138 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2024-02-06

No results posted yet for this study

Summary

The aim of the study is to detect a value of muscle and organ mass measured by body impedance analysis and its correlation with the Medical Research Council (MRC) score. An MRC score ≤ 48 is defined as a diagnosis of ICU acquired weakness. The correlation of the values detected by BIA and their transfer to an MRC Score ≤ 48 will be investigated.

The knowledge gained will be used for early detection of ICUAW in order to reduce the consequences of the same.

Conditions

  • Critical Illness

Interventions

DIAGNOSTIC_TEST

Body Impedance Analysis

Body Impedance Analysis

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Stefan J Schaller, MD · Charite University, Berlin, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-08
Primary Completion
2024-01-28
Completion
2024-01-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05572138 on ClinicalTrials.gov